Delivery Order SPE2DB22D2005-SPE2DB25FJRP0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on August 28, 2025, with a ceiling value of $1,252.52 and an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,774.88 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitive award employs firm fixed pricing under a delivery order contract type with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a competitive delivery order valued at $1,219.47 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units). This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support to the federal government. The award was made without any set-aside designation, indicating it was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Premarin 0.625 mg tablets (100 count) under a firm fixed-price contract structure. This non-set-aside award carries a ceiling value of $1,905.17 and has an ultimate completion date of August 8, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $1,436.56 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) on July 28, 2025. This firm fixed-price delivery order, designated as contract 4568902309, is scheduled for completion by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.15 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.9 mg on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a purchase of a hormone replacement therapy medication supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,583.30 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.45 mg tablets (100-count packages) under a firm fixed-price contract valued at $8,091.47, with an ultimate completion date of August 22, 2025. This non-set-aside competitive award represents a single delivery order fulfilling pharmaceutical supply requirements within the federal medical procurement system. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Premarin 0.625 mg tablets in quantities of 100 with a ceiling value of $1,023.73. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRP0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) under a firm fixed-price contract valued at $9,290.89, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded delivery order was issued on August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a direct procurement of a brand-name hormone replacement therapy medication for military and federal healthcare needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's status as a major pharmaceutical distributor and established federal contractor demonstrates its capability to fulfill federal medical procurement requirements, particularly for the Defense Health Agency and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 8/13/25 |